Related references
Note: Only part of the references are listed.Antiviral effect of phytochemicals from medicinal plants: Applications and drug delivery strategies
Shimon Ben-Shabat et al.
DRUG DELIVERY AND TRANSLATIONAL RESEARCH (2020)
Hepatitis C Virus and Hepatocellular Carcinoma: When the Host Loses Its Grip
Kaku Goto et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Potent HCV NS3 Protease Inhibition by a Water-Soluble Phyllanthin Congener
Uma B. Reddy et al.
ACS OMEGA (2020)
Anthraquinone Derivatives as an Immune Booster and their Therapeutic Option Against COVID-19
Pukar Khanal et al.
NATURAL PRODUCTS AND BIOPROSPECTING (2020)
Comparison of Compliance and Efficacy of Pegylated Interferon α-2a and α-2b in Adults with Chronic Hepatitis C
Jing-Hong Hu et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2019)
A Comprehensive Review of the Structure Elucidation of Tannins from Terminalia Linn.
Zihao Chang et al.
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE (2019)
Discovery of New Inhibitors of Hepatitis C Virus NS3/4A Protease and Its D168A Mutant
Ittipat Meewan et al.
ACS OMEGA (2019)
ADVERPred-Web Service for Prediction of Adverse Effects of Drugs
Sergey M. Ivanov et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2018)
POAP: A GNU parallel based multithreaded pipeline of open babel and AutoDock suite for boosted high throughput virtual screening
A. Samdani et al.
COMPUTATIONAL BIOLOGY AND CHEMISTRY (2018)
Inhibition of Rabies Virus by 1,2,3,4,6-Penta-O-galloyl-β-D-Glucose Involves mTOR-Dependent Autophagy
Zhongzhong Tu et al.
VIRUSES-BASEL (2018)
Newer direct-acting antivirals for hepatitis C virus infection: Perspectives for India
Varun Gupta et al.
INDIAN JOURNAL OF MEDICAL RESEARCH (2017)
Viral hepatitis and liver cancer
Marc Ringehan et al.
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES (2017)
Sequence analysis of hepatitis C virus nonstructural protein 3-4A serine protease and prediction of conserved B and T cell epitopes
Ayesha Naeem et al.
BIOMEDICAL REPORTS (2017)
Pentagalloylglucose, a highly bioavailable polyphenolic compound present in Cortex moutan, efficiently blocks hepatitis C virus entry
Patrick Behrendt et al.
ANTIVIRAL RESEARCH (2017)
Anti-HSV-2 activity of Terminalia chebula Retz extract and its constituents, chebulagic and chebulinic acids
Ajay Kesharwani et al.
BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE (2017)
Hepatoprotective Effect of Terminalia chebula against t-BHP-Induced Acute Liver Injury in C57/BL6 Mice
Min-Kyung Choi et al.
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE (2015)
Hepatitis C virus: A global view
Amal Ahmed Mohamed et al.
WORLD JOURNAL OF HEPATOLOGY (2015)
Hepatitis C virus inhibitory hydrolysable tannins from the fruits of Terminalia chebula
Olusegun S. Ajala et al.
FITOTERAPIA (2014)
A 3D structural model and dynamics of hepatitis C virus NS3/4A protease (genotype 4a, strain ED43) suggest conformational instability of the catalytic triad: implications in catalysis and drug resistivity
Bradley Rimmert et al.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2014)
Broad-spectrum antiviral activity of chebulagic acid and punicalagin against viruses that use glycosaminoglycans for entry
Liang-Tzung Lin et al.
BMC MICROBIOLOGY (2013)
Hepatitis C virus NS5B polymerase primes innate immune signaling
Gisa Gerold et al.
HEPATOLOGY (2013)
Chebulagic Acid, a Hydrolyzable Tannin, Exhibited Antiviral Activity in Vitro and in Vivo against Human Enterovirus 71
Yajun Yang et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2013)
Hepatitis C Virus NS3 Inhibitors: Current and Future Perspectives
Kazi Abdus Salam et al.
BIOMED RESEARCH INTERNATIONAL (2013)
Efficacy of pegylated interferon α-2a and α-2b in patients with genotype 1 chronic hepatitis C: a meta-analysis
Nicola Coppola et al.
BMC INFECTIOUS DISEASES (2012)
Tannin extracts from immature fruits of Terminalia chebula Fructus Retz. promote cutaneous wound healing in rats
Kun Li et al.
BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE (2011)
BindingDB and ChEMBL: online compound databases for drug discovery
Anne Mai Wassermann et al.
EXPERT OPINION ON DRUG DISCOVERY (2011)
Molecular Mechanisms of Viral and Host Cell Substrate Recognition by Hepatitis C Virus NS3/4A Protease
Keith P. Romano et al.
JOURNAL OF VIROLOGY (2011)
Hydrolyzable Tannins (Chebulagic Acid and Punicalagin) Target Viral Glycoprotein-Glycosaminoglycan Interactions To Inhibit Herpes Simplex Virus 1 Entry and Cell-to-Cell Spread
Liang-Tzung Lin et al.
JOURNAL OF VIROLOGY (2011)
Management of adverse effects of Peg-IFN and ribavirin therapy for hepatitis C
Mark S. Sulkowski et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2011)
An overview of HCV molecular biology, replication and immune responses
Usman A. Ashfaq et al.
VIROLOGY JOURNAL (2011)
Pegylated interferon and ribavirin treatment for hepatitis C virus infection
Emilio Palumbo
THERAPEUTIC ADVANCES IN CHRONIC DISEASE (2011)
Tellimagrandin I, HCV invasion inhibitor from Rosae Rugosae Flos
Satoru Tamura et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2010)
Hepatitis C Virus NS3/4A Protease Inhibitors: A Light at the End of the Tunnel
Laurent Chatel-Chaix et al.
VIRUSES-BASEL (2010)
Peginterferon Alfa-2b or Alfa-2a with Ribavirin for Treatment of Hepatitis C Infection
John G. McHutchison et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Hepatitis C and Innate Immunity: Recent Advances
Gyongyi Szabo et al.
CLINICS IN LIVER DISEASE (2008)
Long-term effects of Terminalia chebula Retz. on hyperglycemia and associated hyperlipidemia, tissue glycogen content and in vitro release of insulin in streptozotocin induced diabetic rats
Y. K. Murali et al.
EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES (2007)
Peginterferon alfa-2a and ribavirin for 16 or 24 weeks in HCV genotype 2 or 3
Mitchell L. Shiffman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
How to design multi-target drugs: target search options in cellular networks
Tamas Korcsmaros et al.
EXPERT OPINION ON DRUG DISCOVERY (2007)
BindingDB: a web-accessible database of experimentally determined protein-ligand binding affinities
Tiqing Liu et al.
NUCLEIC ACIDS RESEARCH (2007)
NS3 protein of Hepatitis C virus associates with the tumour suppressor p53 and inhibits its function in an NS3 sequence-dependent manner
Lin Deng et al.
JOURNAL OF GENERAL VIROLOGY (2006)
Terminalia chebula (fruit) prevents liver toxicity caused by sub-chronic administration of rifampicin, isoniazid and pyrazinamide in combination
SA Tasduq et al.
HUMAN & EXPERIMENTAL TOXICOLOGY (2006)
Preliminary immunomodulatory activities of the aqueous extract of Terminalia chebula
HN Shivaprasad et al.
PHARMACEUTICAL BIOLOGY (2006)
Hepatitis C virus protease NS3/4A cleaves mitochondrial antiviral signaling protein off the mitochondria to evade innate immunity
XD Li et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Peginterferon-α2a and ribavirin combination therapy in chronic hepatitis C -: A randomized study of treatment duration and ribavirin dose
SJ Hadziyannis et al.
ANNALS OF INTERNAL MEDICINE (2004)
Antiviral compounds from traditional Chinese medicines Galla chinese as inhibitors of HCVNS3 protease
DL Duan et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2004)
Two antiviral compounds from the plant Stylogne cauliflora as inhibitors of HCVNS3 protease
VR Hegde et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2003)
Cytoscape: A software environment for integrated models of biomolecular interaction networks
P Shannon et al.
GENOME RESEARCH (2003)
Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection.
MW Fried et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Influence of Terminalia chebula on dermal wound healing in rats
L Suguna et al.
PHYTOTHERAPY RESEARCH (2002)
Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial
MP Manns et al.
LANCET (2001)
Share Paper
